title: [Choroidal neovascularization secondary to pseudoxanthoma elasticum treated with ranibizumab: a report of 2 cases].
abstract: METHODS
  We report 2 cases of pseudoxanthoma elasticum with angioid streaks and choroidal neovascularization (CNV) in both eyes. Intravitreal ranibizumab (Lucentis) was administered with successful results in both cases.
  
  
  CONCLUSIONS
  CNV has been reported to occur in 72% to 86% of patients with angioid streaks. Although uncommon, the impact of CNV is important because it tends to affect people of working age. Based on the effectiveness of ranibizumab in other secondary CNVs, we decided to use it in our patients, observing the functional and anatomical improvement.
authors.affiliation: Servicio de Oftalmología, Hospital Universitario Virgen de la Victoria, Málaga, España. anagg 82@hotmail.com
authors.forename: A
authors.initials: A
authors.lastname: González-Gómez
authors.forename: M J
authors.initials: MJ
authors.lastname: Morillo
authors.forename: A B
authors.initials: AB
authors.lastname: González-Escobar
authors.forename: J M
authors.initials: JM
authors.lastname: García-Campos
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000627:therapeutic use*; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections / Q000379:methods; D008297:Male; D008875:Middle Aged; D011561:Pseudoxanthoma Elasticum / Q000150:complications*; D000069579:Ranibizumab; D041623:Tomography, Optical Coherence
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab